HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joseph C. Cleveland, Jr Alden H. Harken Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rowland, R. T. Articles by Brown, J. M. Search for Related Content PubMed PubMed Citation Articles by Rowland, R. T. Articles by Brown, J. M. Related Collections Related Article

Ann Thorac Surg 1995;60:721-728
© 1995 The Society of Thoracic Surgeons

---

Current Review

Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease

Department of Surgery, University of Colorado Health Sciences Center, Denver, Colorado

Gene therapy is the introduction of new genetic material into somatic cells to synthesize missing or defective proteins. Efficient methods for the introduction of genetic material into cells are available, both in vitro and in vivo. These strategies involve chemical, physical, and viral-mediated mechanisms of gene transfer. Application of these gene transfer techniques has led to the development of potential gene-based treatment strategies that could combat vascular and myocardial disease. Gene therapy in the treatment of cardiovascular disease promises to alter atherosclerotic risk factors, prevent vascular thrombotic disease, retard progression of disease in the peripheral vasculature, provide drug delivery systems, and prevent myocardial infarction in patients with coronary artery disease. This exciting technology will eventually become the ultimate intervention in the treatment of cardiovascular disease.

Related Article

Molecular Biology 101

Andrew S. Wechsler
Ann. Thorac. Surg. 1995 60: 497-498. [Extract] [Full Text]

This article has been cited by other articles:

				A. E Basile-Borgia and V. C Ware Life and death of a cardiac myocyte: principles of cellular biology Perfusion, May 1, 2001; 16(3): 229 - 241. [Abstract] [PDF]

				D. K. Das, R. M. Engelman, N. Maulik, J. A. Rousou, J. E. Flack III, and D. W. Deaton Molecular targets of gene therapy Ann. Thorac. Surg., November 1, 1999; 68(5): 1929 - 1933. [Abstract] [Full Text] [PDF]

				A. Basile-Borgia, J. H Abel, and H. Mahloogi Molecular advances in cardiac and cardiovascular disease Perfusion, March 1, 1999; 14(2): 89 - 99. [Abstract] [PDF]

				D. R. Meldrum Tumor necrosis factor in the heart Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R577 - R595. [Abstract] [Full Text] [PDF]

				E. P. Chen, H. B. Bittner, R. D. Davis, P. V. Trigt, and R. J. Folz Physiologic Effects Of Extracellular Superoxide Dismutase Transgene Overexpression On Myocardial Function After Ischemia And Reperfusion Injury J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 450 - 454. [Abstract] [Full Text] [PDF]

				C. J. Magovern, C. A. Mack, J. Zhang, R. T. Hahn, W. Ko, O. W. Isom, R. G. Crystal, and T. K. Rosengart Direct In Vivo Gene Transfer to Canine Myocardium Using a Replication-Deficient Adenovirus Vector Ann. Thorac. Surg., August 1, 1996; 62(2): 425 - 433. [Abstract] [Full Text]

				F. L. Grover The Bright Future of Cardiothoracic Surgery in the Era of Changing Healthcare Delivery Ann. Thorac. Surg., February 1, 1996; 61(2): 499 - 510. [Abstract] [Full Text]

				A. S. Wechsler Molecular Biology 101 Ann. Thorac. Surg., September 1, 1995; 60(3): 497 - 498. [Full Text]